|
Emerging Drug Therapies for Heart Failure
|
Pitchai Balakumar   , Manjeet Singh |
|
|
|
Abstract: (1505 Views) |
| Heart failure is associated with high morbidity and mortality and is proving to be an economic burden in developing countries. A number of therapeutic agents are presently employed in heart failure; but they are not sufficient to control symptoms of heart failure. Moreover, the prevalence of chronic heart failure is progressively increasing and thus there is a continuing need to develop effective therapies for the management of this disease. The present review has discussed various potential therapeutic agents which may open new vistas for the management of heart failure. |
|
| Keywords: Heart failure, Candisartan, Spironolactone, Conivaptan, Nesiritide, Omapatrilat |
|
|
Full-Text [PDF 478 kb]
(637 Downloads)
|
|
Article Type: Research Article |
|
|
|
|
|
|
|
| Add your comments about this article |
|
|
|
